Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Kerstin Lang, Nadine Bonberg, Sibylle Robens, Thomas Behrens, Jan Hovanec, Thomas Deix, Katharina Braun, Florian Roghmann, Joachim Noldus, Volker Harth, Karl-Heinz Jöckel, Raimund Erbel, Yu Chun Tam, Andrea Tannapfel, Heiko Udo Käfferlein, Thomas Brüning
Published Sep 8, 2017 · Vol. 8, No. 62 · pp. 104946-104959
Owen T.M. Chan, Hideki Furuya, Ian Pagano, Yoshiko Shimizu, Kanani Hokutan, Lars Dyrskjøt, Jørgen Bjerggaard Jensen, Per-Uno Malmstrom, Ulrika Segersten, Filip Janku, Charles J. Rosser
Published Sep 6, 2017 · Vol. 8, No. 59 · pp. 99707-99721
Aline R.R. Lima, Luana U. Pagan, Ricardo L. Damatto, Marcelo D.M. Cezar, Camila Bonomo, Mariana J. Gomes, Paula F. Martinez, Daniele M. Guizoni, Dijon H.S. Campos, Felipe C. Damatto, Katashi Okoshi, Marina P. Okoshi
Published Aug 24, 2017 · Vol. 8, No. 47 · pp. 83009-83021